170632 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring nitrogenous groups (2.6)
DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#2Methods and monitoring of treatment with lanifibranor
#3METHODS OF DETERMINING A HEALTH STATUS OF A CAT BASED ON ONE OR MORE BIOMARKERS, AND METHODS OF TREATING A MORTALITY RISK IDENTIFIED BY THE HEALTH STATUS
#4APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS
#5METHOD FOR IDENTIFYING LIVER FIBROSIS
#6COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS
#7Point of Care Assays
#8Device and Methods
#9COMPOSITIONS CONTAINING CHOLINE PROPIONATE FOR CONTROLLING GROWTH OF MOLD AND IMPROVING ANIMAL PERFORMANCE AND RELATED METHODS
#10MR-PROADM MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#11PERSONALIZED MODULATION THERAPY FOR CANCER
#12NON-INVASIVE MONITORING OF LIVER DISEASE TREATMENT
#13A BLOOD PROFILE ANALYSIS METHOD FOR IDENTIFICATION OF NEW DIABETES DIAGNOSTIC MARKERS IN SARS-COV-2 INFECTED PATIENTS
#14ESM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#15SFLT1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#16GDF15 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#17PRESEPSIN MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#18MICROFLUIDIC PLATFORM FOR DETECTION OF LIVER INJURY
#19PCT MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#20IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#21IGFBP7 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#22APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS
#23Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers
#24THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS
#25COMPOSITIONS AND METHODS OF INHIBITING THE BINDING OF PLASMA IGG AUTOANTIBODIES TO SEROTONIN 2A RECEPTOR
#26COMPOSITIONS AND METHODS FOR IDENTIFICATION OF MODULATORS OF RAS PROTEIN COMPLEXES
#27Device and methods
#28DEVICE AND METHODS
#29Systems and methods for sample use maximization
#30Method and System for Identifying Human Individuals Infected with COVID-19 as Being at High Risk of Progression to Severe or Critical Disease
#31Method for quantification of amino acids using cell-free protein synthesis system
#32Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#33Methods for assessing treatment with a gastrointestinal implant
#34Method of diluting a metred quantity of a test fluid for analysis
#35Blood analysis method and blood test kit
#36Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#37Process for in vitro diagnosis of hepatic disorders
#38Systems and methods of sample processing and fluid control in a fluidic system
#39Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#40Systems and methods for sample use maximization
#41COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#42Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#43Treatment of hepatitis delta virus infection
#44Systems and methods for sample use maximization
#45SYSTEMS AND METHODS FOR MULTI-ANALYSIS
#46Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#47Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
#48Kit and method for diagnosis, prognosis or monitoring of liver disease through measurement of amount of AST
#49Test fluid collection system
#50Systems and methods of sample processing and fluid control in a fluidic system
#51Systems and methods for sample use maximization
#52Systems and methods for sample use maximization
#53Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#54Kidney disease biomarker
#55Human hepatoma cell line HLCZ01 and uses thereof
#56Systems and methods for sample use maximization
#57Method of Determining Hypoxia
#58Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#59Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#60Systems and methods of sample processing and fluid control in a fluidic system
#61ENZYME-LOGIC BIOSENSING
#62SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION
#63Methods Of Administration And Treatment
#64USE OF DRONEDARONE FOR THE PREPARATION OF A DRUG FOR USE IN THE MANAGEMENT OF THE RISK OF LIVER INJURY
#65Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
#66FACTORS
#67Quantitative analysis of a biological sample of unknown quantity
#68Serum Biomarkers For Early Detection Of Acute Cellular Rejection
#69Small molecule inhibitors of ghrelin O-acyltransferase
#70GFATS As Modifiers of the AXIN Pathway and Methods of Use
#71METHOD OF DETERMINING ALANINE TRANSAMINASE (ALT) ACTIVITY BY 13C-MR DETECTION USING HYPERPOLARISED 13C-PYRUVATE
#72Specific Acceptors for Transferases to Saccharides and Method for Obtaining and Using Same
#73Measurement of the Activity of a Kynurenine-Converting Enzyme and/or a Kynurenic-Acid, Anthranilic-Acid and/or 3-Hydroxykynurenine-Producing Enzyme
#74Small molecule inhibitors of ghrelin O-acyltransferase
#75SYSTEM FOR ASSAYS OF AMINOTRANSFERASE
#76Quantitative analysis of a biological sample of unknown quantity
#77METHODS FOR DIAGNOSIS OF ACUTE CORONARY SYNDROME
#78Quantitative analysis of a biological sample of unknown quantity
#79Method of determining hypoxia
#80Ornithine aminotransferase (OAT): a target for anticancer drugs
#81Systems and methods of sample processing and fluid control in a fluidic system
#82Methods and kits for the diagnosis of acute coronary syndrome
#83Modulation of nitric oxide signaling through signaling through specific regulation by arginylation and the N-end rule pathway
#84Quantitative analysis of a biological sample of unknown quantity
#85Quantitative analysis of a biological sample of unknown quantity
#86Methods for measuring activity of glutamine:fructose 6-phosphate amidotransferase and activity of inhibitors thereof